Lemaitre Vascular Stock Return On Equity
| LMAT Stock | USD 83.49 2.19 2.56% |
LeMaitre Vascular fundamentals help investors to digest information that contributes to LeMaitre Vascular's financial success or failures. It also enables traders to predict the movement of LeMaitre Stock. The fundamental analysis module provides a way to measure LeMaitre Vascular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LeMaitre Vascular stock.
LeMaitre |
LeMaitre Vascular Company Return On Equity Analysis
LeMaitre Vascular's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current LeMaitre Vascular Return On Equity | 0.14 |
Most of LeMaitre Vascular's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LeMaitre Vascular is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, LeMaitre Vascular has a Return On Equity of 0.1387. This is 100.58% lower than that of the Health Care Equipment & Supplies sector and 102.32% lower than that of the Health Care industry. The return on equity for all United States stocks is 144.74% lower than that of the firm.
LeMaitre Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LeMaitre Vascular's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LeMaitre Vascular could also be used in its relative valuation, which is a method of valuing LeMaitre Vascular by comparing valuation metrics of similar companies.LeMaitre Vascular is currently under evaluation in return on equity category among its peers.
LeMaitre Fundamentals
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0727 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 1.8 B | ||||
| Shares Outstanding | 22.56 M | ||||
| Shares Owned By Insiders | 8.85 % | ||||
| Shares Owned By Institutions | 95.58 % | ||||
| Number Of Shares Shorted | 1.25 M | ||||
| Price To Earning | 38.99 X | ||||
| Price To Book | 5.67 X | ||||
| Price To Sales | 8.79 X | ||||
| Revenue | 219.86 M | ||||
| Gross Profit | 150.9 M | ||||
| EBITDA | 66.75 M | ||||
| Net Income | 44.04 M | ||||
| Cash And Equivalents | 75.68 M | ||||
| Cash Per Share | 3.45 X | ||||
| Total Debt | 185.69 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 6.34 X | ||||
| Book Value Per Share | 14.96 X | ||||
| Cash Flow From Operations | 44.12 M | ||||
| Short Ratio | 6.02 X | ||||
| Earnings Per Share | 1.93 X | ||||
| Price To Earnings To Growth | 2.23 X | ||||
| Target Price | 105.63 | ||||
| Number Of Employees | 651 | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 1.93 B | ||||
| Total Asset | 551.82 M | ||||
| Retained Earnings | 145.09 M | ||||
| Working Capital | 371.58 M | ||||
| Current Asset | 58.18 M | ||||
| Current Liabilities | 10.37 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.93 % | ||||
| Net Asset | 551.82 M | ||||
| Last Dividend Paid | 0.64 |
About LeMaitre Vascular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LeMaitre Vascular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LeMaitre Vascular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LeMaitre Vascular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.